What to do when a patient’s asthma control deteriorates after switching to a more environmentally friendly, or ‘greener’, ...

Patients who switched from a pressurized metered dose inhaler (pMDIs) to a dry powder inhaler (DPI) halved their carbon footprints while still maintaining good asthma control, a post-hoc analysis of ...

Changing to a dry powder inhaler (DPI) was associated with more healthcare use by adult patients with asthma, based on data from approximately 260,000 individuals. The Veterans Health Administration ...

In both the Easyhaler DPI and Evohaler pMDI cohorts, 98.3% of patients with asthma recovered FEV1 to at least -10% of baseline after their last treatment post MC test. Investigators sought to ...

The most important advantage of inhaled delivery of medicines is that they are delivered directly into the airways and lungs, resulting in higher local concentrations, lower systemic exposure and ...

The Food and Drug Administration (FDA) has approved Tyvaso DPI™ (treprostinil) inhalation powder for the treatment of pulmonary arterial hypertension (PAH; WHO Group 1) and pulmonary hypertension ...

Investigators using real-world data found that patients receiving treatment from slow mist inhalers (SMIs) had fewer exacerbations and hospitals readmissions compared with patients using dry powder ...

Healthcare professionals showed a lack of knowledge about how to assess and teach proper inhaler technique to their patients with chronic obstructive pulmonary disease (COPD), asthma, or other ...